|
| | Publication Year | Title | Author(s) |
| 21 | 29-Jul-2022 | A critical evaluation of the role of iron overload in fatty liver disease. | Fernandez, Monique; Lokan, Julie ; Leung, Christopher ; Grigg, Andrew P |
| 22 | Jul-2022 | Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre. | Tam, Constantine S; Gregory, Gareth P; Ku, Matthew; Fleming, Shaun; Handunnetti, Sasanka M; Lee, Denise; Walker, Patricia; Perkins, Andrew; Lew, Thomas E; Sirdesai, Shreerang; Chua, Chong Chyn ; Gilbertson, Michael; Lasica, Masa; Anderson, Mary Ann; Renwick, William; Grigg, Andrew P ; Patil, Sush; Opat, Stephen; Friebe, Adam; Cooke, Rachel; De Boer, Jasper; Spencer, Andrew; Ritchie, David; Agarwal, Rishu ; Blombery, Piers |
| 23 | 20-Jun-2022 | Living Long and Well After an Autograft. | Grigg, Andrew P |
| 24 | Jun-2022 | Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement. | Enjeti, Anoop K; Agarwal, Rishu ; Blombery, Piers; Chee, Lynette; Chua, Chong Chyn ; Grigg, Andrew P ; Hamad, Nada; Iland, Harry; Lane, Steven; Perkins, Andrew; Singhal, Deepak; Tate, Courtney; Tiong, Ing Soo; Ross, David M |
| 25 | 16-May-2022 | Toxicity associated with high-dose intravenous methotrexate for hematological malignancies. | Wight, Joel C ; Ku, Matthew; Garwood, Melissa; Carradice, Duncan; Lasica, Masa; Keamy, Louise; Hawkes, Eliza A ; Grigg, Andrew P |
| 26 | May-2022 | Real-world tolerability of venetoclax-based maintenance therapy with azole antifungal prophylaxis for acute myeloid leukemia in remission. | Nguyen, Phillip C; Donati, Vanessa; Vassili, Catherine; Grigg, Andrew P ; Tiong, Ing S |
| 27 | 28-Mar-2022 | The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma. | Rees, Matthew J ; Panigrahi, Ashish; Harrison, Simon J; Spencer, Andrew; Khong, Tiffany; Gibbs, Simon; Hocking, Jay; Grigg, Andrew P ; Zantomio, Daniela |
| 28 | 2022 | Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study. | Evens, Andrew M; Connors, Joseph M; Younes, Anas; Ansell, Stephen M; Kim, Won Seog; Radford, John; Feldman, Tatyana; Tuscano, Joseph; Savage, Kerry J; Oki, Yasuhiro; Grigg, Andrew P ; Pocock, Christopher; Dlugosz-Danecka, Monika; Fenton, Keenan; Forero-Torres, Andres; Liu, Rachael; Jolin, Hina; Gautam, Ashish; Gallamini, Andrea |
| 29 | 2022 | Very late-onset hepatitis B reactivation following chemoimmunotherapy. | Cliff, Edward R Scheffer; Sasadeusz, Joe; Visvanathan, Kumar; Grigg, Andrew P |
| 30 | 2-Nov-2021 | Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. | Stadtmauer, Edward A; Sullivan, Keith M; El Idrissi, Mohamed; Salaun, Bruno; Alonso Alonso, Aránzazu; Andreadis, Charalambos; Anttila, Veli-Jukka; Bloor, Adrian Jc; Broady, Raewyn; Cellini, Claudia; Cuneo, Antonio; Dagnew, Alemnew F; Di Paolo, Emmanuel; Eom, HyeonSeok; González-Rodríguez, Ana Pilar; Grigg, Andrew ; Guenther, Andreas; Heineman, Thomas C; Jarque, Isidro; Kwak, Jae-Yong; Lucchesi, Alessandro; Oostvogels, Lidia; Polo Zarzuela, Marta; Schuind, Anne E; Shea, Thomas C; Sinisalo, Ulla Marjatta; Vural, Filiz; Yáñez San Segundo, Lucrecia; Zachée, Pierre; Bastidas, Adriana |
| 31 | Sep-2021 | The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft. | Rees, Matthew J ; Mollee, Peter; Ng, Jun Yen; Murton, Alex; Gonsalves, Jose Filipe; Panigrahi, Ashish; Beer, Hayley; Loh, Joanna; Nguyen, Philip; Hunt, Sam; Jina, Hayden; Wayte, Rebecca; Sutrave, Gaurav; Tan, Jocelyn; Abeyakoon, Chathuri; Chee, Ashlyn; Augustson, Bradley; Kalro, Akash; Lee, Cindy; Agrawal, Shivam; Churilov, Leonid ; Chua, Chong Chyn ; Lim, Andrew Boon Ming ; Zantomio, Daniela ; Grigg, Andrew P |
| 12 | 4-Aug-2021 | Safe administration of obinutuzumab to rituximab-intolerant patients. | Manos, Kate ; Grigg, Andrew P |
| 13 | 26-Jul-2021 | Dilemmas in the diagnosis and pathogenesis of atypical late-onset familial haemophagocytic lymphohistiocytosis. | Minson, Adrian; Voskoboinik, Ilia; Grigg, Andrew P |
| 14 | Jun-2021 | Genomics analysis of leukaemia predisposition in X-linked agammaglobulinaemia. | Nishimura, Akira; Naruto, Takuya; Miyamoto, Satoshi; Grigg, Andrew P ; Bosco, Julian J; Hoshino, Akihiro; Amano, Keishiro; Iwamoto, Shotaro; Hirayama, Masahiro; Migita, Masahiro; Ohara, Osamu; Takagi, Masatoshi; Morio, Tomohiro; van Zelm, Menno C; Kanegane, Hirokazu |
| 15 | 26-Apr-2021 | The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia. | Rees, Matthew J ; Wu, Simon; Mokoonlall, Mridula; Dix, Caroline H K; Bryant, Christian E; D'Rozario, James; Schwarer, Anthony P ; Grigg, Andrew P ; Tiong, Ing S |
| 16 | 2-Mar-2021 | Myeloid somatic mutation panel testing in myeloproliferative neoplasms. | Ross, David M; Thomson, Candice; Hamad, Nada; Lane, Steven W; Manos, Kate ; Grigg, Andrew P ; Guo, Belinda; Erber, Wendy N; Scott, Ashleigh; Viiala, Nick; Chee, Lynette; Latimer, Maya; Tate, Courtney; Grove, Carolyn; Perkins, Andrew C; Blombery, Piers |
| 17 | Mar-2021 | Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low-intensity chemotherapy in acute myeloid leukaemia. | Tiong, Ing S ; Dillon, Richard; Ivey, Adam; Teh, Tse-Chieh; Nguyen, Phillip; Cummings, Nicholas; Taussig, David C; Latif, Annie-Louise; Potter, Nicola E; Runglall, Manohursingh; Russell, Nigel H; Raj, Kavita; Schwarer, Anthony P ; Fong, Chun Yew ; Grigg, Andrew P ; Wei, Andrew H |
| 18 | Mar-2021 | Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. | Lewis, Katharine L; Chin, Collin K; Manos, Kate ; Casey, John; Hamad, Nada; Crawford, Julie; Ho, Shir-Jing; Issa, Samar; Grigg, Andrew P ; Wood, Peter; Gandhi, Maher K; Do, Bryan; Nastoupil, Loretta; Hawkes, Eliza A ; Cheah, Chan Y |
| 19 | 25-Dec-2020 | Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. | Straus, David; Collins, Graham; Walewski, Jan; Zinzani, Pier Luigi; Grigg, Andrew P ; Sureda, Anna; Illes, Arpad; Kim, Tae Min; Alekseev, Sergey; Specht, Lena; Buccheri, Valeria; Younes, Anas; Connors, Joseph; Forero-Torres, Andres; Fenton, Keenan; Gautam, Ashish; Purevjal, Indra; Liu, Rachael; Gallamini, Andrea |
| 20 | Dec-2020 | Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. | Mir, Farheen; Mattiello, Federico; Grigg, Andrew P ; Herold, Michael; Hiddemann, Wolfgang; Marcus, Robert; Seymour, John F; Bolen, Christopher R; Knapp, Andrea; Nielsen, Tina; Casulo, Carla |
Loading...
2
0
20
0
false